INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845PAA6 Class: NOTE 3.250% 7/0

UBS Group AG's Holding History (CIK: 0001610520)

Note: Option positions (PUT/CALL) are excluded.

Q1 2021
Shares 7,000 Value ($000) $6 Avg Close — Range —
Q4 2020
Shares 7,000 Value ($000) $5 Avg Close — Range —
Q3 2020
Shares 6,000 Value ($000) $5 Avg Close — Range —
Q2 2020
Shares 6,000 Value ($000) $5 Avg Close — Range —
Q4 2018
Shares 2,218,000 Value ($000) $2,044 Avg Close — Range —
Q3 2018
Shares 5,968,000 Value ($000) $6,031 Avg Close — Range —
Q2 2018
Shares 7,968,000 Value ($000) $6,976 Avg Close — Range —
Q1 2018
Shares 7,229,000 Value ($000) $5,792 Avg Close — Range —
Q4 2017
Shares 2,280,000 Value ($000) $1,813 Avg Close — Range —
Q3 2017
Shares 1,380,000 Value ($000) $1,066 Avg Close — Range —
Q2 2017
Shares 5,048,000 Value ($000) $4,909 Avg Close — Range —
Q1 2017
Shares 8,050,000 Value ($000) $7,502 Avg Close — Range —
Q4 2016
Shares 14,758,000 Value ($000) $13,153 Avg Close — Range —
Q3 2016
Shares 8,558,000 Value ($000) $9,569 Avg Close — Range —